All Stories

  1. Rich oleocanthal and oleacein extra virgin olive oil and inflammatory and antioxidant status in people with obesity and prediabetes. The APRIL study: A randomised, controlled crossover study
  2. Lansoprazole Increases Inorganic Pyrophosphate in Patients with Pseudoxanthoma Elasticum: A Double-Blind, Randomized, Placebo-Controlled Crossover Trial
  3. NR5A2/LRH-1 regulates the PTGS2-PGE2-PTGER1 pathway contributing to pancreatic islet survival and function
  4. Insulin-like Growth Factor II Prevents MPP+ and Glucocorticoid Mitochondrial-Oxidative and Neuronal Damage in Dopaminergic Neurons
  5. Plasma Concentrations of Lysophosphatidic Acid and Autotaxin in Abstinent Patients with Alcohol Use Disorder and Comorbid Liver Disease
  6. Impact of Glucocorticoid on a Cellular Model of Parkinson’s Disease: Oxidative Stress and Mitochondrial Function
  7. Acute Lung Injury Biomarkers in the Prediction of COVID-19 Severity: Total Thiol, Ferritin and Lactate Dehydrogenase
  8. Serum Biomarkers in Differential Diagnosis of Idiopathic Pulmonary Fibrosis and Connective Tissue Disease-Associated Interstitial Lung Disease
  9. Cutaneous and Vascular Deposits of 18F-NaF by PET/CT in the Follow-Up of Patients with Pseudoxanthoma Elasticum
  10. Pro-fibrotic Factors as Potential Biomarkers of Anti-fibrotic Drug Therapy in Patients With Idiopathic Pulmonary Fibrosis
  11. Role of patients associations in connective tissue calcifiying diseases: a position statement from EuroSoftCalc.Net group
  12. Neuronal Metabolism and Neuroprotection: Neuroprotective Effect of Fingolimod on Menadione-Induced Mitochondrial Damage
  13. Relationship Between Mitochondrial Structure and Bioenergetics in Pseudoxanthoma elasticum Dermal Fibroblasts
  14. Neuronal Metabolism and Neuroprotection. Neuroprotective Effect of Fingolimod on Menadione Induced Mitochondrial Damage
  15. Treadmill Exercise Buffers Behavioral Alterations Related to Ethanol Binge-Drinking in Adolescent Mice
  16. Skin and Arterial Wall Deposits of 18F-NaF and Severity of Disease in Patients with Pseudoxanthoma Elasticum
  17. Macular choroidal thickness in patients with pseudoxanthoma elasticum measured by enhanced-depth imaging spectral-domain optical coherence tomography
  18. The Atypical Cannabinoid Abn-CBD Reduces Inflammation and Protects Liver, Pancreas, and Adipose Tissue in a Mouse Model of Prediabetes and Non-alcoholic Fatty Liver Disease
  19. LPA1 receptor and chronic stress: Effects on behaviour and the genes involved in the hippocampal excitatory/inhibitory balance
  20. Plasma inorganic pyrophosphate and alkaline phosphatase in patients with pseudoxanthoma elasticum
  21. Inadequate control of thyroid hormones sensitizes to hepatocarcinogenesis and unhealthy aging
  22. Effects of the LPA1 Receptor Deficiency and Stress on the Hippocampal LPA Species in Mice
  23. The S1P mimetic fingolimod phosphate regulates mitochondrial oxidative stress in neuronal cells
  24. Alcohol-induced cognitive deficits are associated with decreased circulating levels of the neurotrophin BDNF in humans and rats
  25. Systemic blockade of LPA1/3 lysophosphatidic acid receptors by ki16425 modulates the effects of ethanol on the brain and behavior
  26. Training memory without aversion: Appetitive hole-board spatial learning increases adult hippocampal neurogenesis
  27. The Effects of Parenteral K1 Administration in Pseudoxanthoma Elasticum Patients Versus Controls. A Pilot Study
  28. Central administration of galanin N-terminal fragment 1-15 decreases the voluntary alcohol intake in rats
  29. IGF-II promotes neuroprotection and neuroplasticity recovery in a long-lasting model of oxidative damage induced by glucocorticoids
  30. maLPA1-null mice as an endophenotype of anxious depression
  31. Involvement of IGF-II receptors in the antioxidant and neuroprotective effects of IGF-II on adult cortical neuronal cultures
  32. Ectopic calcification in β-thalassemia patients is associated with increased oxidative stress and lower MGP carboxylation
  33. Fear extinction and acute stress reactivity reveal a role of LPA1 receptor in regulating emotional-like behaviors
  34. Chronic Immobilization in the malpar1Knockout Mice Increases Oxidative Stress in the Hippocampus
  35. Liver mitochondrial dysfunction is reverted by insulin-like growth factor II (IGF-II) in aging rats
  36. Hepatoprotection and neuroprotection induced by low doses of IGF-II in aging rats
  37. Imágenes funduscópicas con autofluorescencia en pacientes con pseudoxantoma elástico
  38. Fibroblast protein profile analysis highlights the role of oxidative stress and vitamin K recycling in the pathogenesis of pseudoxanthoma elasticum
  39. Enhanced actions of insulin-like growth factor-I and interferon-α co-administration in experimental cirrhosis
  40. Parameters of oxidative stress are present in the circulation of PXE patients
  41. Low Doses of Insulin-Like Growth Factor I Improve Insulin Resistance, Lipid Metabolism, and Oxidative Damage in Aging Rats
  42. Low Doses of Insulin-Like Growth Factor-I Induce Mitochondrial Protection in Aging Rats
  43. Plasma redox status is impaired in the portacaval shunted rat – the risk of the reduced antioxidant ability
  44. Mitochondrial protection by low doses of insulin-like growth factor-Iin experimental cirrhosis
  45. Little effects of Insulin-like Growth Factor-I on testicular atrophy induced by hypoxia
  46. Antioxidant effects of insulin-like growth factor-I (IGF-I) in rats with advanced liver cirrhosis
  47. Oxidative stress in fibroblasts from patients with pseudoxanthoma elasticum: possible role in the pathogenesis of clinical manifestations
  48. Essential requirement of reduced glutathione (GSH) for the anti-oxidant effect of the flavonoid quercetin
  49. Jejunal microvilli atrophy and reduced nutrient transport in rats with advanced liver cirrhosis: improvement by Insulin-like Growth Factor I
  50. 5-HT1AReceptor Activation before Acute Stress Counteracted the Induced Long-Term Behavioral Effects
  51. Use of the fluorescent dye 10-N-nonyl acridine orange in quantitative and location assays of cardiolipin: a study on different experimental models
  52. Hematotesticular barrier is altered from early stages of liver cirrhosis: Effect of insulin-like growth factor 1
  53. Multidrug resistance protein-6 (MRP6) in human dermal fibroblasts. Comparison between cells from normal subjects and from Pseudoxanthoma elasticum patients
  54. Effect of IGF-I on total serum antioxidant status in cirrhotic rats
  55. Local (gut) and systemic metabolism of rats is altered by consumption of raw bean (Phaseolus vulgarisL. var.athropurpurea)
  56. IGF1 gene transfer into skeletal muscle using recombinant adeno-associated virus in a rat model of liver cirrhosis
  57. Insulin-like growth factor-I restores the reduced somatostatinergic tone controlling growth hormone secretion in cirrhotic rats
  58. Antifibrogenic effect in vivo of low doses of insulin-like growth factor-I in cirrhotic rats
  59. UCP2 muscle gene transfer modifies mitochondrial membrane potential
  60. Changes in intramitochondrial cardiolipin distribution in apoptosis-resistant HCW-2 cells, derived from the human promyelocytic leukemia HL-60
  61. Effects of IGF-I treatment on osteopenia in rats with advanced liver cirrhosis
  62. Insulin-like growth factor-I reverts testicular atrophy in rats with advanced cirrhosis
  63. Osteopenia in rats with liver cirrhosis: beneficial effects of IGF-I treatment
  64. Hepatoprotective effects of insulin-like growth factor I in rats with carbon tetrachloride-induced cirrhosis
  65. Impaired intestinal sugar transport in cirrhotic rats: Correction by low doses of insulin-like growth factor I